ICRF Chicago is proud to honor Harvey L. Miller and Family - Jan & Harvey Miller, Diane & Steve Miller, Lori & Tony Khanuk.
The Harvey L. Miller Family believes in giving back to the community - and they do it with total commitment. Among Jan and Harvey Miller's many charitable contributions, the most significant to ICRF is their extraordinary gift creating the Jacki and Bruce Barron Cancer Research Scholars' Program. This visionary endeavor is an international collaboration among ICRF research scientists and City of Hope investigators that is invaluable in the quest to cure cancers.
Jan and Harvey have served as inspirations to their children. Their son, Steve Miller, has found success as a venture capitalist and co-founder of Origin Ventures. Among their charitable giving portfolio, Steve and his wife Diane have established the Diane N. and Steven N. Miller Centennial Chair in Business at the University of Illinois, are active in sustaining the Victory Gardens Theatre, and are loyal supporters of ICRF.
Jan and Harvey's daughter, Lori, and her husband Tony Khanuk are also impressive philanthropists. With grants from their anonymous foundation they have helped further the careers of young ICRF scientists.
ICRF Chicago is excited to be joined by special guest Jacob Hanna, Ph.D. - M.D., Assistant Professor, The Department of Molecular Genetics, Weizmann Institute of Science, Israel.
Jacob Hanna, Ph.D., M.D. is Assistant Professor in the Department of Molecular Genetics at Weizmann Institute of Science, Israel. He has previously received two consecutive three-year Research Career Development Awards from ICRF. He earned his B.Sc. in Medical Sciences and Ph.D. in clinical medicine from the Hebrew University of Jerusalem, Israel. His lab at the Weizmann Institute combines experimentation methods and computational biology to explore topics in embryonic stem cell biology, early embryonic development and the modeling of human diseases. In addition to helping elucidate the molecular basis of cell programing, his research offers the promise of creating powerful research models for cancer. Dr. Hanna's line of research may revolutionize treatments for infertility, including that increasingly encountered in female cancer survivors. Dr. Hanna holds numerous honors and fellowships and was featured among "40 under 40" innovative scientists by Cell press (2014) and recently became an EMBO member for excellence in the life sciences (2017).